Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Yatai Pharma Subsidiary Shengyao Guangyan Signs LOI to Acquire BODIPY‑Type Photosensitizer for Acne – Class 1.1 Photodynamic Asset with Up to RMB 65 Million in Milestones Plus Royalties
CompanyDeals

Yatai Pharma Subsidiary Shengyao Guangyan Signs LOI to Acquire BODIPY‑Type Photosensitizer for Acne – Class 1.1 Photodynamic Asset with Up to RMB 65 Million in Milestones Plus Royalties

Zhejiang Shengyao Guangyan Pharmaceutical Co., Ltd. ("Shengyao Guangyan"), a wholly‑owned subsidiary of Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE: 002370), signed a Letter of Intent (LOI) for Innovative Drug Technology Transaction…

Regeneron Reports Positive 84‑Week Phase 3 OPTIMA Results for Pasatru in FOP – No New Heterotopic Ossification Lesions After Week 56 vs Nine for Placebo

Regeneron Reports Positive 84‑Week Phase 3 OPTIMA Results for Pasatru in FOP – No New Heterotopic Ossification Lesions After Week 56 vs Nine for Placebo

AbbVie Announces Phase 3 AFFIRM Data for SKYRIZI Subcutaneous Induction in Crohn's Disease – 35.8% Achieved Endoscopic Remission

AbbVie Announces Phase 3 AFFIRM Data for SKYRIZI Subcutaneous Induction in Crohn’s Disease – 35.8% Achieved Endoscopic Remission

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Mabwell Receives NMPA Approval for Clinical Trial of 9MW3011 in Rare Diseases

CompanyDrug

3D Medicines Gains FDA Approval for Phase II Study of Envafolimab in dMMR Tumors

CompanyDrug

Guangdong Zhongsheng Completes Enrollment for RAY1216 Phase III Study in COVID-19

CompanyDrug

Chinagene Tech’s ZVS101e Receives FDA IND Approval for Bietti’s Crystalline Dystrophy

CompanyDrug

CSPC’s ALMB-0168 Receives NMPA Approval for Osteoarthritis Clinical Study

CompanyDrug

RemeGen’s RC108 Receives FDA Go-Ahead for Phase I Clinical Study

CompanyDrug

BrightGene Receives NMPA Approval for BGM0504 Clinical Trial

Drug

Anhui Anke Biotechnology Receives NMPA Approval for AK2017 Clinical Study

Show More